
The New Era of Cancer Treatment: How Subcutaneous Injections are Revolutionizing Patient Care
FDA approval of subcutaneous nivolumab injections marks a new frontier in cancer treatment, offering improved patient experiences and operational efficiencies. Subcutaneous delivery serves as a convenient alternative to intravenous (IV) treatments, aligning with patient lifestyles and needs. This method reduces treatment time,